Indian Stock Market Forecast

The Indian stock market is expected to open on a steady note on Wednesday, March 18, 2026, supported by positive global cues. Trends in the GIFT Nifty also signal a mildly upbeat start for domestic markets, trading near the 23,648 mark, reflecting a premium of about 31 points over the previous close of Nifty futures.

Market Analysis

The Indian equity market is expected to open on a cautious yet steady note, as it attempts to extend the recovery seen over the past two sessions. This improvement is largely supported by value buying across key sectors such as metals, auto, banking, and select large-cap stocks, indicating that investors are gradually stepping back into the market after recent corrections.

Read also: Treasury Yields Experience Largest Increase in Two Weeks Following Release of Labor Market Data

Market Performance

On Tuesday, March 17, 2026, the Indian stock market posted strong gains, with the Nifty 50 closing above the 23,500 level. The Sensex surged 567.99 points, or 0.75%, to end at 76,070.84, while the Nifty 50 advanced 172.35 points, or 0.74%, to settle at 23,581.15.

Stocks to Watch

• Urban Company: DF International Partners II LLC, an early investor, exited its entire holding in the tech-enabled home services platform through a block deal on Tuesday, March 17, 2026.
• Tata Steel: The company's board approved the merger of NINL with the company, along with a $2 billion investment in its wholly owned subsidiary, T Steel Holdings Pte.
• Maruti Suzuki: The automaker received a draft assessment order from the Income Tax Authority amounting to ₹5,786 crore.
• Tech Mahindra: The IT company signed a share sale and purchase agreement to acquire a 20% equity stake in Tech Mahindra Arabia Ltd, another subsidiary of the firm.
• Varun Beverages: The FMCG company's South Africa-based subsidiary signed an agreement to acquire a 100% equity stake in Crickley Dairy Proprietary.
• Wipro: The company announced a strategic partnership with Harness to fast-track AI-native software delivery for global enterprises.
• PNB: The state-run bank invited bids for the sale of non-performing assets (NPAs) of Rolta Pvt Ltd worth ₹450.85 crore.
• Aurobindo Pharma: The pharmaceutical company stated that the US Food and Drug Administration (FDA) has classified one of its subsidiary facilities as "Official Action Indicated" (OAI) following an inspection.
• Ceigall India: The company's wholly owned subsidiary was declared the lowest (L1) bidder for two tenders issued by the Punjab Infrastructure Development Board.
• Strides Pharma: The company signed definitive agreements with Sandoz AG and its group entities to acquire and in-license a portfolio of branded generic products across sub-Saharan Africa.

Read also: US-Iran Tensions Spark Uptick in Oil Prices Amid Global Market Decline